Product information
From Health Canada
The product monograph is developed by a drug sponsor according to guidelines published by Health Canada that provide direction on the content and format. The veterinary labelling is developed by the drug sponsor according to the Food and Drug Regulations. While Health Canada reviews the product monograph or the veterinary labelling as part of the drug review process, it remains the responsibility of the drug sponsor to ensure that the product monograph or the veterinary labelling is complete and accurate.
Current status:
Marketed
Current status date:
2020-08-13
Original market date: See footnote 1
2011-04-28
Product name:
MOVIPREP
DIN:
02359499
Product Monograph/Veterinary Labelling:
Date:
2021-08-20
Product monograph/Veterinary Labelling (PDF version ~ 175K)
Company:
ARALEZ PHARMACEUTICALS CANADA INC
800
6733 Mississauga Rd
Mississauga
Ontario
Canada
L5N 6J5
Class:
Human
Dosage form(s):
Powder For Solution
Route(s) of administration:
Oral
Number of active ingredient(s):
6
Schedule(s):
Ethical
American Hospital Formulary Service (AHFS): See footnote 3
56:12.00
Anatomical Therapeutic Chemical (ATC): See footnote 4
A06AD65 MACROGOL, COMBINATIONS
Active ingredient group (AIG) number:See footnote5
0652827001
| Active ingredient(s) | Strength |
|---|---|
| ASCORBIC ACID | 4.7 G / SACHET |
| POLYETHYLENE GLYCOL 3350 | 100 G / SACHET |
| POTASSIUM CHLORIDE | 1.015 G / SACHET |
| SODIUM ASCORBATE | 5.9 G / SACHET |
| SODIUM CHLORIDE | 2.691 G / SACHET |
| SODIUM SULFATE ANHYDROUS | 7.5 G / SACHET |